New multiple action intestinal hormone corrects diabetes




Scientists have developed a new therapeutic approach for treatment of Type 2 diabetes. A novel single molecule hormone, which acts equally on the receptors of the insulin-stimulating hormones GLP-1 and GIP, was observed to reduce weight and improve blood sugar.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/E...

Miércoles, 30 de Octubre 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección